跳到主要內容

Ryan Arthur F 的 Form 4 申報

Regeneron Pharmaceuticals, Inc.(REGN),2024/4/3 申報

申報編號
0001968202-24-000090
申報時間
2024/4/3
交易日
2024/4/1
申報延遲
2 天
10b5-1 計畫
有勾選

這份申報列了 9 筆非衍生性交易。公開市場賣出合計 $9.63 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Ryan Arthur FCIK 0001187443董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2024/4/1Common StockS賣出處分−2$957.78−$1,915.5618,280直接
2024/4/1Common StockS賣出處分−2$958.86−$1,917.7218,278直接
2024/4/1Common StockS賣出處分−9$959.47F2−$8,635.2318,269直接
2024/4/1Common StockS賣出處分−15$960.53F3−$14,407.9518,254直接
2024/4/1Common StockS賣出處分−14$961.59F4−$13,462.2618,240直接
2024/4/1Common StockS賣出處分−9$962.42F5−$8,661.7818,231直接
2024/4/1Common StockS賣出處分−20$963.60F6−$19,27218,211直接
2024/4/1Common StockS賣出處分−16$964.45F7−$15,431.218,195直接
2024/4/1Common StockS賣出處分−13$965.35F8−$12,549.5518,182直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Represents volume-weighted average price of sales of 9 shares of Company stock on April 1, 2024 at prices ranging from $959.13 to $959.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F3

Represents volume-weighted average price of sales of 15 shares of Company stock on April 1, 2024 at prices ranging from $960.06 to $960.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents volume-weighted average price of sales of 14 shares of Company stock on April 1, 2024 at prices ranging from $961.10 to $961.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents volume-weighted average price of sales of 9 shares of Company stock on April 1, 2024 at prices ranging from $962.06 to $962.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F6

Represents volume-weighted average price of sales of 20 shares of Company stock on April 1, 2024 at prices ranging from $963.02 to $963.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F7

Represents volume-weighted average price of sales of 16 shares of Company stock on April 1, 2024 at prices ranging from $964.02 to $964.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F8

Represents volume-weighted average price of sales of 13 shares of Company stock on April 1, 2024 at prices ranging from $965.00 to $965.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)